EMA Conflict Of Interest Guidelines Sets Up Five-Year Exclusion Window For Committee Chairs
Executive Summary
The European Medicines Agency has reviewed its conflict of interest policy for members of its Scientific Committees with a view to ensuring that they are not unduly influenced by the pharmaceutical industry.